Ascendis Pharma Tech Stack

Biopharmaceutical company developing therapies via TransCon platform technology

Biotechnology Research Hellerup, Capital Region of Denmark 1,001–5,000 employees Founded 2007 Public Company

Ascendis Pharma is a Copenhagen-headquartered biopharmaceutical company operating across endocrinology and oncology with a public equity base and ~1,000–5,000-person workforce. The tech stack reveals a mature regulatory and compliance infrastructure (Veeva suite, SAS JMP, IQVIA) paired with modern data engineering (Databricks, dbt, PySpark on Azure), suggesting a company investing in both clinical-trial data processing and real-world performance analytics. Hiring skews heavily toward sales and healthcare roles (78 of 162 open positions), with only 9 engineering hires active — a pattern typical of late-stage pharma scaling commercial and medical-affairs functions rather than product platform work.

Tech Stack 42 technologies

Core StackDatabricks dbt GitHub Actions PySpark Azure Data Factory Hyper-V Active Directory Windows Server Azure AD ServiceNow Power BI Azure Spark SQL HPLC Veeva PromoMats Git Dynamics 365 Finance and Operations SharePoint VMware vSphere Windows Microsoft 365 Microsoft Office Veeva Quality Vault Cornerstone LMS Veeva Vault SAS JMP Veeva RIM SailPoint Identity Security Cloud IQVIA Komodo+12 more

What Ascendis Pharma Is Building

◆Challenges

Improving patient access to therapy
Ensuring timely access to therapies
Reducing treatment barriers
Pharma compliance requirements
Challenging market access scenarios
Navigating insurance coverage and reimbursement
Reimbursement process complexity
Reimbursement challenges
Complex referral networks
National expansion

▲Active Projects

Strategies to improve patient access to therapy
Training and onboarding programs for new pals
Adverse event reporting
Territory business plan
Patient education symposia
Launch of yorvipath
Local access strategy development
Process improvement initiatives for operational efficiency
Risk management plan development
Patient access and reimbursement support

Hiring Activity

Steady160 roles · 50 in 30d

Department

Sales

Healthcare

Support

Engineering

Marketing

Data

Finance

Ops

Seniority

Senior

Mid

Director

Manager

Intern

Lead

Junior

Notable leadership hires: Sales Director, Regional Sales Director, Medical Director, Head of Market Access, Medical Affairs Director

Company intelligence

Find more companies like Ascendis Pharma by tech stack, pain points and active projects

Get started free

About Ascendis Pharma

Ascendis Pharma applies its proprietary TransCon technology platform to develop therapies targeting unmet medical needs in endocrinology and oncology. The company operates globally from Denmark, Switzerland, Germany, Italy, the United Kingdom, and the United States, with an organizational focus on patient access, regulatory compliance, and market expansion. Active projects center on therapy access barriers, reimbursement strategy, patient education, and product launches, reflecting a commercial-stage biotech balancing clinical development with healthcare-system navigation and payer relationships. Pain points cluster around insurance coverage, referral complexity, and national market entry—operational challenges endemic to pharmaceutical commercialization.

HeadquartersHellerup, Capital Region of Denmark

Company Size1,001–5,000 employees

Founded2007

Hiring MarketsUnited States, Switzerland, Germany, Denmark, Italy, United Kingdom

Frequently Asked Questions

What tech does Ascendis Pharma use for data and clinical analytics?

Ascendis runs Databricks, dbt, and PySpark on Azure Data Factory for data engineering; SAS JMP and IQVIA for statistical and real-world evidence analysis; and Veeva suite (Vault, Quality Vault, RIM, PromoMats) for regulatory and quality compliance.

Is Ascendis Pharma hiring sales and medical roles?

Yes. Of 162 active roles, 46 are sales positions and 32 are healthcare/medical roles. Recent leadership hires include Sales Director, Regional Sales Director, Medical Director, and Head of Market Access.